Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
Figure 9.Experimental verification of SHCBP1 mRNA expression by qRT-PCR analysis in various cancers. (A) Gastric cancer (B) Colorectal cancer (C) Liver cancer. *P<0.05; **P<0.01; ***P<0.001.